Literature DB >> 36185956

Malignant Peripheral Nerve Sheath Tumor of the Adrenal Gland: A De novo Case.

Raiz A Misgar1, Mohammad S Baba1, Mir I Bashir1, Arshad I Wani1.   

Abstract

Entities:  

Year:  2022        PMID: 36185956      PMCID: PMC9519828          DOI: 10.4103/ijem.ijem_120_22

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
Sir, Malignant peripheral nerve sheath tumors (MPNSTs), which arise from peripheral nerve branches or sheaths of peripheral nerve fibers,[1] are rarely present in adrenal glands.[23456789] Most of these tumors occur in association with neurofibromatosis, ganglioneuroma, or pheochromocytoma.[8] We report extremely rare case of a MPNST of adrenal gland not associated with neurofibromatosis, ganglioneuroma, or pheochromocytoma. A 40-year-old female with Type 2 diabetes mellitus (on metformin 500 mg and teneligliptin 20 mg) and hypertension (on telmisartan 40 mg) for 3 years was referred to our endocrine center for the evaluation of left adrenal mass, which was detected incidentally on ultrasonography abdomen, done for vague abdominal pain of one week duration. The general physical and systemic examination was unremarkable. Contrast-enhanced computed tomographic scan of the abdomen showed left adrenal mass, 6 cm in maximum dimension with necrosis. Precontrast Hounsfield units (HU) 40, portal venous phase HU140, delayed phase HU 90, absolute washout 50% and delayed washout 35.7% [Figure 1]. Overnight 1 mg dexamethasone suppression test (0.4 mg/dL), 24 urinary metanephrines 100 mg (74–297 mg/24 hours), normetanephrines 120 mg (73–800 mg/24 hours) and serum dehydroepiandrosterone sulfate 1.2 ng/mL (0.36–7.82 ng/mL) were normal. She was subjected to open left adrenalectomy.
Figure 1

Contrast enhanced CT scan of the abdomen showing left adrenal mass with necrosis (arrow)

On gross examination, the tumor measured 10 × 5 × 6 cm, replaced the entire adrenal gland, was encapsulated and cut surface was yellowish-white with small areas of hemorrhages. Microscopy revealed a spindle cell neoplasm arranged in a whorling pattern [Figure 2], high cellularity, numerous mitotic figures, and zones of tumor necrosis [Figure 3] with positive immunoreactivity for S100 protein and vimentin. The tumor cells were negative for cytokeratin (CK), smooth muscle antigen (SMA), desmin, epithelial membrane antigen (EMA), and Melan A. The patient is on follow up and is doing well 3 years after the surgery. A recent PET-CT has shown no evidence of recurrent or metastatic disease.
Figure 2

Microphotograph revealing MPNST with spindle cells in a whorling arrangement (arrow) (H and E ×400)

Figure 3

Microphotograph revealing zones of tumor necrosis (arrow) (H and E ×400)

Contrast enhanced CT scan of the abdomen showing left adrenal mass with necrosis (arrow) Microphotograph revealing MPNST with spindle cells in a whorling arrangement (arrow) (H and E ×400) Microphotograph revealing zones of tumor necrosis (arrow) (H and E ×400) MPNST is a rare soft tissue sarcoma of ectomesenchymal origin. To the best of our knowledge, only 8 cases of MPNST of the adrenal gland has been reported in the literature [Table 1] and 7 of these occur in association with neurocutaneous syndromes.[23456789] Our case is only the second report of adrenal MPNST without any history of neurofibromatosis or combined tumor. These tumors often have histopathological similarities with other spindle cell sarcomas such as leiomyosarcoma and fibrosarcoma. In 50 to 90% of MPNSTs, the cells are immunoreactive to S-100 protein staining.[10] Patients with MPNSTs have a poor prognosis and metastasize to the lung, liver, brain, soft tissue, bone, regional lymph nodes, skin, or retroperitoneum. Adverse prognostic factors for MPNST include tumor size ≥10 cm, partial resection, nuclear p53 expression and lack of S-100 immunoreactivity.[11]
Table 1

Summary of reported cases of adrenal MPNST

AuthorAge/sexTumor siteComposite tumor or related diseaseTreatment
Chandrasoma et al.[2]30/MLeftGanglioneuromaAdrenalectomy
Min et al.[3]39/FLeftPheochromocytomaAdrenalectomy
Miettinen et al.[4]38/FLeftPheochromocytomaAdrenalectomy
Sakaguchi et al.[5]48/MBilateralNeurofibromatosis PheochromocytomaRadiation Chemotherapy
Ch’ng et al.[6]37/FLeftPheochromocytomaAdrenalectomy and Nephrectomy
Namekawa et al.[7]42/FLeftPheochromocytomaAdrenalectomy and Nephrectomy
Park et al.[8]31/FLeft followed by rightDe novoAdrenalectomy
Baisakh et al.[9]24/MLeftNeurofibromatosisAdrenalectomy
Present case40/FLeftDe novoAdrenalectomy

MPNST: malignant peripheral nerve sheath tumor

Summary of reported cases of adrenal MPNST MPNST: malignant peripheral nerve sheath tumor

CONCLUSION

MPNST of the adrenal gland is extremely rare and this is only the second report about MPNST of the adrenal gland without any history of neurofibromatosis or combined tumor.

Consent

Informed and written consent was obtained from the patient for participation the study and data publication.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  10 in total

1.  SARCOMAS OF THE PERIPHERAL NERVES AND SOMATIC SOFT TISSUES ASSOCIATED WITH MULTIPLE NEUROFIBROMATOSIS (VON RECKLINGHAUSEN'S DISEASE).

Authors:  A N D'AGOSTINO; E H SOULE; R H MILLER
Journal:  Cancer       Date:  1963-08       Impact factor: 6.860

2.  Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumour: a case with 28 years of tumour-bearing history.

Authors:  E S Ch'ng; Y Hoshida; N Iizuka; E Morii; J-I Ikeda; A Yamamoto; Y Tomita; H Hanasaki; T Katsuya; K Maeda; M Ohishi; H Rakugi; T Ogihara; K Aozasa
Journal:  Histopathology       Date:  2007-09       Impact factor: 5.087

3.  Immunohistochemical evaluation of Leu-7, myelin basic-protein, S100-protein, glial-fibrillary acidic-protein, and LN3 immunoreactivity in nerve sheath tumors and sarcomas.

Authors:  M D Johnson; A D Glick; B W Davis
Journal:  Arch Pathol Lab Med       Date:  1988-02       Impact factor: 5.534

4.  Pheochromocytoma combined with malignant schwannoma: unusual neoplasm of the adrenal medulla.

Authors:  M Miettinen; A Saari
Journal:  Ultrastruct Pathol       Date:  1988 Sep-Oct       Impact factor: 1.094

5.  A case of von Recklinghausen's disease with bilateral pheochromocytoma-malignant peripheral nerve sheath tumors of the adrenal and gastrointestinal autonomic nerve tumors.

Authors:  N Sakaguchi; K Sano; M Ito; T Baba; M Fukuzawa; M Hotchi
Journal:  Am J Surg Pathol       Date:  1996-07       Impact factor: 6.394

6.  Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.

Authors:  Changye Zou; Kerrington D Smith; Jun Liu; Guy Lahat; Sarah Myers; Wei-Lien Wang; Wei Zhang; Ian E McCutcheon; John M Slopis; Alexander J Lazar; Raphael E Pollock; Dina Lev
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

Review 7.  Composite pheochromocytoma with a malignant peripheral nerve sheath tumor: Case report and review of the literature.

Authors:  Takeshi Namekawa; Takanobu Utsumi; Takashi Imamoto; Koji Kawamura; Takashi Oide; Tomoaki Tanaka; Naoki Nihei; Hiroyoshi Suzuki; Yukio Nakatani; Tomohiko Ichikawa
Journal:  Asian J Surg       Date:  2013-02-20       Impact factor: 2.767

8.  Malignant peripheral nerve sheath tumor arising in an adrenal ganglioneuroma in an adult male homosexual.

Authors:  P Chandrasoma; D Shibata; R Radin; L P Brown; M Koss
Journal:  Cancer       Date:  1986-05-15       Impact factor: 6.860

9.  Malignant peripheral nerve sheath tumor and pheochromocytoma. A composite tumor of the adrenal.

Authors:  K W Min; A Clemens; J Bell; H Dick
Journal:  Arch Pathol Lab Med       Date:  1988-03       Impact factor: 5.534

10.  Malignant peripheral nerve sheath tumor of adrenal gland with heterologus osseous differentiation in a case of Von Recklinghausen's disease.

Authors:  Manas R Baisakh; Nachiketa Mohapatra; Samiran D Adhikary; Debasis Routray
Journal:  Indian J Pathol Microbiol       Date:  2014 Jan-Mar       Impact factor: 0.740

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.